skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Proteasome Stress Sensitizes Malignant Pleural Mesothelioma Cells to Bortezomib-Induced Apoptosis

; ; ; ; ; ; ; ; ; ORCiD logo;
Publication Date:
Research Org.:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Org.:
OSTI Identifier:
Resource Type:
Journal Article
Journal Name:
Scientific Reports
Additional Journal Information:
Journal Volume: 7; Journal Issue: 1; Journal ID: ISSN 2045-2322
Nature Publishing Group
Country of Publication:
United States

Citation Formats

Cerruti, Fulvia, Jocollè, Genny, Salio, Chiara, Oliva, Laura, Paglietti, Luca, Alessandria, Beatrice, Mioletti, Silvia, Donati, Giovanni, Numico, Gianmauro, Cenci, Simone, and Cascio, Paolo. Proteasome Stress Sensitizes Malignant Pleural Mesothelioma Cells to Bortezomib-Induced Apoptosis. United States: N. p., 2017. Web. doi:10.1038/s41598-017-17977-9.
Cerruti, Fulvia, Jocollè, Genny, Salio, Chiara, Oliva, Laura, Paglietti, Luca, Alessandria, Beatrice, Mioletti, Silvia, Donati, Giovanni, Numico, Gianmauro, Cenci, Simone, & Cascio, Paolo. Proteasome Stress Sensitizes Malignant Pleural Mesothelioma Cells to Bortezomib-Induced Apoptosis. United States. doi:10.1038/s41598-017-17977-9.
Cerruti, Fulvia, Jocollè, Genny, Salio, Chiara, Oliva, Laura, Paglietti, Luca, Alessandria, Beatrice, Mioletti, Silvia, Donati, Giovanni, Numico, Gianmauro, Cenci, Simone, and Cascio, Paolo. Fri . "Proteasome Stress Sensitizes Malignant Pleural Mesothelioma Cells to Bortezomib-Induced Apoptosis". United States. doi:10.1038/s41598-017-17977-9.
title = {Proteasome Stress Sensitizes Malignant Pleural Mesothelioma Cells to Bortezomib-Induced Apoptosis},
author = {Cerruti, Fulvia and Jocollè, Genny and Salio, Chiara and Oliva, Laura and Paglietti, Luca and Alessandria, Beatrice and Mioletti, Silvia and Donati, Giovanni and Numico, Gianmauro and Cenci, Simone and Cascio, Paolo},
abstractNote = {},
doi = {10.1038/s41598-017-17977-9},
journal = {Scientific Reports},
issn = {2045-2322},
number = 1,
volume = 7,
place = {United States},
year = {2017},
month = {12}

Works referenced in this record:

The Active Sites of the Eukaryotic 20 S Proteasome and Their Involvement in Subunit Precursor Processing
journal, October 1997

  • Heinemeyer, Wolfgang; Fischer, Michael; Krimmer, Thomas
  • Journal of Biological Chemistry, Vol. 272, Issue 40
  • DOI: 10.1074/jbc.272.40.25200

Regulatory mechanisms controlling biogenesis of ubiquitin and the proteasome
journal, May 2004

Gene Expression Profiles Predict Survival and Progression of Pleural Mesothelioma
journal, February 2004

Prophylactic radiotherapy to prevent procedure-tract metastases
journal, October 2016

Two abundant proteasome subtypes that uniquely process some antigens presented by HLA class I molecules
journal, October 2010

  • Guillaume, B.; Chapiro, J.; Stroobant, V.
  • Proceedings of the National Academy of Sciences, Vol. 107, Issue 43
  • DOI: 10.1073/pnas.1009778107

PA28αβ: The Enigmatic Magic Ring of the Proteasome?
journal, June 2014

Transcription Factor Nrf1 Mediates the Proteasome Recovery Pathway after Proteasome Inhibition in Mammalian Cells
journal, April 2010

Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations
journal, February 2016

  • Bueno, Raphael; Stawiski, Eric W.; Goldstein, Leonard D.
  • Nature Genetics, Vol. 48, Issue 4
  • DOI: 10.1038/ng.3520

Chemical Profiling of Primary Mesothelioma Cultures Defines Subtypes with Different Expression Profiles and Clinical Responses
journal, October 2017

  • Schunselaar, Laurel M.; Quispel-Janssen, Josine M. M. F.; Kim, Yongsoo
  • Clinical Cancer Research, Vol. 24, Issue 7
  • DOI: 10.1158/1078-0432.CCR-17-1345

Vorinostat Eliminates Multicellular Resistance of Mesothelioma 3D Spheroids via Restoration of Noxa Expression
journal, December 2012

Proteasome inhibitors in the treatment of multiple myeloma
journal, September 2009

Pivotal Advance: Protein synthesis modulates responsiveness of differentiating and malignant plasma cells to proteasome inhibitors
journal, November 2012

  • Cenci, Simone; Oliva, Laura; Cerruti, Fulvia
  • Journal of Leukocyte Biology, Vol. 92, Issue 5
  • DOI: 10.1189/jlb.1011497

Proteasome allostery as a population shift between interchanging conformers
journal, November 2012

  • Ruschak, A. M.; Kay, L. E.
  • Proceedings of the National Academy of Sciences, Vol. 109, Issue 50
  • DOI: 10.1073/pnas.1213640109

The recognition of ubiquitinated proteins by the proteasome
journal, May 2016

  • Grice, Guinevere L.; Nathan, James A.
  • Cellular and Molecular Life Sciences, Vol. 73, Issue 18
  • DOI: 10.1007/s00018-016-2255-5

Targeted proteasome inhibition by Velcade induces apoptosis in human mesothelioma and breast cancer cell lines
journal, December 2009

  • Wang, Ying; Rishi, Arun K.; Puliyappadamba, Vineshkumar T.
  • Cancer Chemotherapy and Pharmacology, Vol. 66, Issue 3
  • DOI: 10.1007/s00280-009-1181-8

Proteasome inhibitors: from research tools to drug candidates
journal, January 2001

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
journal, August 2008

  • San Miguel, Jesús F.; Schlag, Rudolf; Khuageva, Nuriet K.
  • New England Journal of Medicine, Vol. 359, Issue 9
  • DOI: 10.1056/NEJMoa0801479

Molecular Pathways: Targeting Proteasomal Protein Degradation in Cancer
journal, October 2011

Quantitative Proteomics Reveals the Function of Unconventional Ubiquitin Chains in Proteasomal Degradation
journal, April 2009

The Proteasome: Paradigm of a Self-Compartmentalizing Protease
journal, February 1998

Structure and Functions of the 20S and 26S Proteasomes
journal, June 1996

Dampening Ab responses using proteasome inhibitors followingin vivo B cell activation
journal, March 2008

  • Cascio, Paolo; Oliva, Laura; Cerruti, Fulvia
  • European Journal of Immunology, Vol. 38, Issue 3
  • DOI: 10.1002/eji.200737743

Bortezomib Inhibits Nuclear Factor- B Dependent Survival and Has Potent In vivo Activity in Mesothelioma
journal, October 2007

Characterization of a new series of non-covalent proteasome inhibitors with exquisite potency and selectivity for the 20S β5-subunit
journal, August 2010

  • Blackburn, Christopher; Gigstad, Kenneth M.; Hales, Paul
  • Biochemical Journal, Vol. 430, Issue 3
  • DOI: 10.1042/BJ20100383

PA28αβ Reduces Size and Increases Hydrophilicity of 20S Immunoproteasome Peptide Products
journal, April 2014

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
journal, June 2011

  • Bott, Matthew; Brevet, Marie; Taylor, Barry S.
  • Nature Genetics, Vol. 43, Issue 7
  • DOI: 10.1038/ng.855

Rapid degradation of a large fraction of newly synthesized proteins by proteasomes
journal, April 2000

  • Schubert, Ulrich; Antón, Luis C.; Gibbs, James
  • Nature, Vol. 404, Issue 6779
  • DOI: 10.1038/35008096

Identification of Novel Candidate Oncogenes and Tumor Suppressors in Malignant Pleural Mesothelioma Using Large-Scale Transcriptional Profiling
journal, June 2005

  • Gordon, Gavin J.; Rockwell, Graham N.; Jensen, Roderick V.
  • The American Journal of Pathology, Vol. 166, Issue 6
  • DOI: 10.1016/S0002-9440(10)62492-3

An evolutionarily conserved pathway controls proteasome homeostasis
journal, July 2016

An immunoaffinity purification method for the proteomic analysis of ubiquitinated protein complexes
journal, September 2013

  • Schwertman, Petra; Bezstarosti, Karel; Laffeber, Charlie
  • Analytical Biochemistry, Vol. 440, Issue 2
  • DOI: 10.1016/j.ab.2013.05.020

Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
journal, March 2009

What is the survival after surgery for localized malignant pleural mesothelioma?†
journal, January 2013

  • Gelvez-Zapata, Sandra M.; Gaffney, Daniel; Scarci, Marco
  • Interactive CardioVascular and Thoracic Surgery, Vol. 16, Issue 4
  • DOI: 10.1093/icvts/ivs542

Proteasome inhibitor PSI induces apoptosis in human mesothelioma cells
journal, February 2006

Asbestos-induced lung diseases: an update
journal, April 2009

Phase II Clinical Experience With the Novel Proteasome Inhibitor Bortezomib in Patients With Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma
journal, February 2005

  • O'Connor, Owen A.; Wright, John; Moskowitz, Craig
  • Journal of Clinical Oncology, Vol. 23, Issue 4
  • DOI: 10.1200/JCO.2005.02.050

New therapeutic options for mesothelioma
journal, August 2005

The Caspase-like Sites of Proteasomes, Their Substrate Specificity, New Inhibitors and Substrates, and Allosteric Interactions with the Trypsin-like Sites
journal, June 2003

  • Kisselev, Alexei F.; Garcia-Calvo, Margarita; Overkleeft, Herman S.
  • Journal of Biological Chemistry, Vol. 278, Issue 38
  • DOI: 10.1074/jbc.M303725200

The Bcl-2 repertoire of mesothelioma spheroids underlies acquired apoptotic multicellular resistance
journal, June 2011

  • Barbone, D.; Ryan, J. A.; Kolhatkar, N.
  • Cell Death & Disease, Vol. 2, Issue 6
  • DOI: 10.1038/cddis.2011.58

Phase II Clinical Trial of First or Second-Line Treatment with Bortezomib in Patients with Malignant Pleural Mesothelioma
journal, September 2012

Molecular Basis of Differential Sensitivity of Myeloma Cells to Clinically Relevant Bolus Treatment with Bortezomib
journal, February 2013

Molecular Classification of Malignant Pleural Mesothelioma: Identification of a Poor Prognosis Subgroup Linked to the Epithelial-to-Mesenchymal Transition
journal, January 2014

The development of proteasome inhibitors as anticancer drugs
journal, May 2004

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
journal, July 2003

  • Vogelzang, Nicholas J.; Rusthoven, James J.; Symanowski, James
  • Journal of Clinical Oncology, Vol. 21, Issue 14
  • DOI: 10.1200/JCO.2003.11.136

Comprehensive Pharmacogenomic Profiling of Malignant Pleural Mesothelioma Identifies a Subgroup Sensitive to FGFR Inhibition
journal, October 2017

  • Quispel-Janssen, Josine M.; Badhai, Jitendra; Schunselaar, Laurel
  • Clinical Cancer Research, Vol. 24, Issue 1
  • DOI: 10.1158/1078-0432.CCR-17-1172

Progressively impaired proteasomal capacity during terminal plasma cell differentiation
journal, February 2006

Proteasome Inhibitors: An Expanding Army Attacking a Unique Target
journal, January 2012

Biologic Impact of Proteasome Inhibition in Multiple Myeloma Cells—From the Aspects of Preclinical Studies
journal, July 2012

Advances in Malignant Mesothelioma
journal, October 2005

  • Robinson, Bruce W. S.; Lake, Richard A.
  • New England Journal of Medicine, Vol. 353, Issue 15
  • DOI: 10.1056/NEJMra050152

Advances in the systemic therapy of malignant pleural mesothelioma
journal, January 2008

  • Fennell, Dean A.; Gaudino, Giovanni; O'Byrne, Kenneth J.
  • Nature Clinical Practice Oncology, Vol. 5, Issue 3
  • DOI: 10.1038/ncponc1039

Mammalian Target of Rapamycin Contributes to the Acquired Apoptotic Resistance of Human Mesothelioma Multicellular Spheroids
journal, March 2008

  • Barbone, Dario; Yang, Tsung-Ming; Morgan, Jeffrey R.
  • Journal of Biological Chemistry, Vol. 283, Issue 19
  • DOI: 10.1074/jbc.M709698200

Enhanced rate of degradation of basic proteins by 26S immunoproteasomes
journal, September 2014

  • Raule, Mary; Cerruti, Fulvia; Cascio, Paolo
  • Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, Vol. 1843, Issue 9
  • DOI: 10.1016/j.bbamcr.2014.05.005

Proteasome Inhibitor MG132 Induces Apoptosis and Inhibits Invasion of Human Malignant Pleural Mesothelioma Cells
journal, September 2008

  • Yuan, Bao-Zhu; Chapman, Joshua A.; Reynolds, Steven H.
  • Translational Oncology, Vol. 1, Issue 3
  • DOI: 10.1593/tlo.08133

An Overview of Chemotherapy for Mesothelioma
journal, December 2005

Proteasome Inhibitors in Cancer Therapy: Lessons from the First Decade
journal, March 2008

The 26S Proteasome: A Molecular Machine Designed for Controlled Proteolysis
journal, June 1999

Malignant pleural mesothelioma: Genome-wide expression patterns reflecting general resistance mechanisms and a proposal of novel targets
journal, January 2010

Malignant Pleural Mesothelioma
journal, April 2009

  • Tsao, Anne S.; Wistuba, Ignacio; Roth, Jack A.
  • Journal of Clinical Oncology, Vol. 27, Issue 12
  • DOI: 10.1200/JCO.2008.19.8523

Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma
journal, May 2007

  • Gordon, Gavin J.; Mani, Madhubalan; Maulik, Gautam
  • Cancer Chemotherapy and Pharmacology, Vol. 61, Issue 4
  • DOI: 10.1007/s00280-007-0500-1